Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value

BACKGROUND: Immunohistochemical assessment of proliferation may provide additional prognostic information in early breast cancer. However, due to a lack of methodological standards proliferation markers are still not routinely used for determining therapy. Even for Ki67, one of the most widely-studi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Joshi, Shalaka, Watkins, Johnathan, Gazinska, Patrycja, Brown, John P., Gillett, Cheryl E., Grigoriadis, Anita, Pinder, Sarah E.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4513675/
https://ncbi.nlm.nih.gov/pubmed/26205655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1531-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars